Through the ASCO Lens: A Perspective on the Present and Future of Oncology

Maurie Markman, MD
Published: Saturday, Sep 23, 2017
Maurie Markman, MD

Maurie Markman, MD
The clinical oncology community, along with patients, families, pharmaceutical companies, investors, and third-party payers, eagerly awaits the plenary session presentations at the American Society of Clinical Oncology (ASCO) annual meetings as representing the most important and impactful of the thousands of abstracts submitted each year. In any given year, the abstracts selected by ASCO’s Scientific Program Committee range from interesting to paradigm changing but always represent, in the opinion of the committee and ASCO’s leadership, first-class clinical or translational investigative efforts.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Advances in™ Therapies for Patients With ALK-Positive Lung Cancers: More Options…More Decisions…Better OutcomesAug 30, 20191.5
Community Practice Connections™: PARP Inhibition in Breast Cancer: Practical Methods to Interpret and Apply the Evidence for Your PatientsAug 30, 20191.5
Publication Bottom Border
Border Publication
x